CHEK2 and hypoparathyroidism-retardation-dysmorphism syndrome: Approximately 4.7% of PDAC patients carry the BRCA1 and the BRCA2 gene mutations, and 2.5% harbor HRD-related genes, such as ATM, checkpoint kinase 2 (CHEK2), and PALB2 [177].